Seegene Receives Health Canada Approval for its new Allplex™ Respiratory Molecular Test

 Seegene Receives Health Canada Approval for its new Allplex™ Respiratory Molecular Test   Gaithersburg, Maryland and SEOUL, Korea, March 2, 2015 ? Seegene Inc. (096530.KQ), a lea...

Seegene Receives FDA Clearance for its Herpes Simplex Virus Molecular Test

? Gaithersburg, Maryland and SEOUL, Korea, February17, 2015?Seegene Inc.(096530.KQ), a leading developer of multiplex PCR technologies, today announced that the U.S. Food and Drug Administratio...

Seegene to Present at the 33rd annual J.P. Morgan Healthcare Conference

Seegene to Present at the 33rd annual J.P. Morgan Healthcare Conference ?Gaithersburg, Maryland and SEOUL, Korea, January 5, 2014 ? Seegene Inc. (096530.KQ), a leading developer of multiplex ...

Seegene Introduces Allplex™ Assays Based on MuDT™ Next-Generation qPCR Technology

Seegene Submits First MDx to FDA with More Highly Multiplexed Test to Follow in 2015

Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology That Doubles the Channel Availability of Any Real-Time PCR Instrument

Seegene to unveil at AACC 2014 the innovative real-time PCR technology that doubles the channel availability of any real-time PCR instrument Gaithersburg, Maryland and SEOUL, Korea, July 22, 20...

Seegene Announces the World’s First Real-time PCR Technology for Multi-C_t in a Single Channel

 New "MDisc" technology breathes new life into real-time PCR by overcoming the challenge of "one channel, one Ct"   Gaithersburg, Maryland and SEOUL, Korea, May12, 2014 ?Seegene...

Seegene to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Seegene to Present at the 32nd Annual J.P. Morgan Healthcare Conference GAITHERSBURG, MD and SEOUL, KOREA--(Marketwired - Dec 19, 2013) - Seegene Inc., (KOSDAQ: 096530), a leading developer...

Seegene Develops Novel Real-Time Array Technology for Point of Care Testing (POCT)

Seegene and Eidia Collaborate to Bring New Multiplex Molecular Diagnostic Tests to Japan

Seegene and Eidia Collaborate to Bring New Multiplex Molecular Diagnostic Tests to Japan Gaithersburg, Maryland and SEOUL, Korea, July 1, 2013 ? Seegene Inc. (KOSDAQ: 096530), a leading develop...

Seegene to feature extended mutation detection technology for companion diagnostics at AACC 2013

Seegeneto feature extended mutation detection technology for companion diagnostics at AACC 2013 Seegene’s novel multiplex real-time PCR to simultaneously detect and differentiate over 20 mutati...

Seegene develops highly multiplexed diagnostic tests that enable cost-effective, responsive, and tailored patient care

Multiplex molecular diagnostics: shifting the paradigm

Seegene Names John G. Hurrell as Senior Executive Vice President

Seegene Names John G. Hurrell as Senior Executive Vice President Seegene Inc. (KOSDAQ: 096530), a leading developer of multiplex molecular technologies and multiplex molecular diagnostic tests,...